Ezetimibe, is a leading medication in cholesterol management. Developed by Merck, Ezetimibe is renowned for its effectiveness in reducing LDL cholesterol levels by inhibiting its absorption in the intestine. This unique mechanism makes it an essential option for patients who need additional cholesterol control beyond diet and exercise. Ezetimibe’s commitment to cardiovascular health is supported by extensive clinical research and proven efficacy. With a global presence, Zetia ensures broad accessibility for those in need. By continuously investing in research and patient education, Ezetimibe empowers individuals to manage their cholesterol effectively and reduce the risk of cardiovascular events.